Literature DB >> 10701514

Viability of the EUD and TCP concepts as reliable dose indicators.

M A Ebert1.   

Abstract

The concept of equivalent uniform dose (EUD) was introduced to provide a method of reporting radiotherapy dose distributions which takes account of the nonlinearity of tissue dose-response, whilst not attempting to make predictions of absolute outcome. The purpose of this investigation was to determine the level of sensitivity of EUD to model parameters for significant variations in dose distribution and consequently the reliability of the factor as a dose-indicator, and to compare EUD with the more familiar index, tumour control probability (TCP). EUD and TCP, derived from the linear-quadratic formalism, were investigated for a test tissue being irradiated non-uniformly. Variations in the parameters of the model (tissue cell characteristics, dose heterogeneity, fractionation parameters) indicated the sensitivity of EUD and TCP to them. For time independent factors--cell density, cell radiosensitivity, radiosensitivity heterogeneity (population averaged) and ratio alpha/beta--EUD was found to vary insignificantly in comparison with TCP, though this is a function of the actual form of the dose distribution under consideration. For fractionated treatments where the mean dose per fraction is varying (due to dosimetric/positioning errors for example), both EUD and TCP showed little variation with the degree of dose non-uniformity. For other time dependent factors, fractionation rate and cell repopulation times, TCP again showed significant variation relative to EUD. The relative insensitivity of EUD implies that this index will be useful for dose evaluation when parameters are not known with accuracy, for the intercomparison of dose control studies and as a radiobiologically based optimization objective. However, given confidence in model parameters, the sensitivity of TCP would make it a more reliable tool for indicating potentially successful and unsuccessful irradiation strategies. It is suggested that both parameters be used in conjunction, with EUD and TCP results viewed with an appreciation of the characteristics of each model.

Entities:  

Mesh:

Year:  2000        PMID: 10701514     DOI: 10.1088/0031-9155/45/2/313

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  13 in total

1.  Optimization of radiotherapy fractionation schedules based on radiobiological functions.

Authors:  Fernando Pizarro; Araceli Hernández
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

Review 2.  Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT).

Authors:  Ryoichi Seki; Yushi Wakisaka; Nami Morimoto; Masaaki Takashina; Masahiko Koizumi; Hiroshi Toki; Mitsuhiro Fukuda
Journal:  Radiol Phys Technol       Date:  2017-11-20

3.  Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.

Authors:  Brian A Hrycushko; Alonso N Gutierrez; Beth Goins; Weiqiang Yan; William T Phillips; Pamela M Otto; Ande Bao
Journal:  Phys Med Biol       Date:  2011-02-07       Impact factor: 3.609

4.  Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.

Authors:  Brian A Hrycushko; Steve Ware; Shihong Li; Ande Bao
Journal:  Phys Med Biol       Date:  2011-08-12       Impact factor: 3.609

5.  (Radio)biological optimization of external-beam radiotherapy.

Authors:  Alan E Nahum; Julien Uzan
Journal:  Comput Math Methods Med       Date:  2012-11-06       Impact factor: 2.238

6.  Dosimetric Effects of Magnetic Resonance Imaging-assisted Radiotherapy Planning: Dose Optimization for Target Volumes at High Risk and Analytic Radiobiological Dose Evaluation.

Authors:  Ji-Yeon Park; Tae Suk Suh; Jeong-Woo Lee; Kook-Jin Ahn; Hae-Jin Park; Bo-Young Choe; Semie Hong
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

7.  The perils of adapting to dose errors in radiation therapy.

Authors:  Velibor V Mišić; Timothy C Y Chan
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

8.  Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma.

Authors:  Jin Wang; Yuan-Yuan Chen; An Tai; Xue-Lin Chen; Shao-Ming Huang; Cungen Yang; Yong Bao; Ning-Wei Li; Xiao-Wu Deng; Chong Zhao; Ming Chen; X Allen Li
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

9.  Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.

Authors:  Mark Ka Heng Chan; Chi-Leung Chiang
Journal:  Strahlenther Onkol       Date:  2020-11-27       Impact factor: 3.621

10.  Quantification of the uncertainties within the radiotherapy dosimetry chain and their impact on tumour control.

Authors:  Matthew Bolt; Catharine H Clark; Andrew Nisbet; Tao Chen
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.